5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Cardiac Genetic Disorders
Cardiac genetic disorders, a subset of genetic conditions affecting the heart, involve abnormalities in the genes responsible for the structure and function of the cardiovascular system. These disorders can manifest in various forms, impacting heart development, rhythm, or overall function. Some conditions may predispose individuals to congenital heart defects, while others may influence the risk of arrhythmias or cardiomyopathies. Understanding the genetic basis of cardiac disorders is crucial for early diagnosis, risk assessment, and personalized treatment strategies. Advances in genetic testing and research are shedding light on the intricate relationship between genetics and heart health, offering hope for improved interventions and tailored approaches to manage and mitigate the impact of cardiac genetic disorders.
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas J Webster
Brown University, United States
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain